FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Cell Viability Assays Market Overview:

According to FutureWise analysis the market for cell viability assays in 2023 is US$ 1.53 billion, and is expected to reach US$ 3.32 billion by 2031 at a CAGR of 10.2%.

Cell viability assays are technologies that are used for determining the cell strength in response to any tested drug. They are generally tested on a tissue, cell or an organ. Cell viability looks for the cells to identify any inorganic reaction which they aren’t supposed to follow and scale this reaction to mark its viability. This plays an important role in all forms of cell culture. Cell viability forms the basis of an assay to look out for drug effectiveness or cell viability with multiple combined particles and it also offers different characteristics of cell health to the user.

Cell viability assay is primarily performed in all in vitro and pharmaceutical studies due to increased applications of cell viability assays for drug screening. A large number of local manufacturers have expanded their cell viability assay kits product portfolio to determine effects in cell growth and cell death for the sake of clinical research and this has increased the demand for cell viability assays thus aiding the cell viability assays market size proliferation.

Major Players included in the Cell Viability Assays Market:

Thermo Fisher Scientific
Merck KGaA
Bio-Rad Laboratories
GE Healthcare
Danaher Corporation
Becton
Dickinson and Company
Promega Corporation
Biotium
Abcam PLC
Creative Bioarray
Biotek Instruments
PerkinElmer

(Note: The list of the major players will be updated with the latest market scenario and trends)

Cell Viability Assays Market Segmentation:

By Product

Consumables
- Reagents
- Assay Kits
  - Tetrazolium Reduction Assay Kits
    - Mtt Assay Kits
    - Other Tetrazolium Assay Kits
  - Resazurin Cell Viability Assay Kits
  - Calcein-Am Cell Viability Assay Kits
  - Other Assay Kits
- Microplates
Instruments
- Automated Cell Counters
- Flow Cytometers
- Spectrophotometers
- Cell Imaging and Analysis Systems

By Cell Type

Human Cells
Animal Cells
Microbial Cells

By Application

Drug Discovery and Development
Basic Research
Stem Cell Research
Clinical and Diagnostic Applications
Other Applications

By End User

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospital and Diagnostic Laboratories
Other End Users

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Competitive Landscape:

Tier 1 players-established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global Cell Viability Assays Market By Product, By Cell Type, By Application, By End User and By Region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)—North America, Asia Pacific, Europe, Latin America and Middle East and Africa
To record evaluate and competitive landscape mapping-product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization services offered are free of charge with purchase of any license of the report.
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Global Cell Viability Assays Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Cell Viability Assays Market Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Cell Viability Assays Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Global Cell Viability Assays Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Consumables
  1.1. Reagents
  1.2. Assay Kits
  1.2.1. Tetrazolium Reduction Assay Kits
  1.2.1.1. Mtt Assay Kits
  1.2.1.2. Other Tetrazolium Assay Kits
  1.2.2. Resazurin Cell Viability Assay Kits
  1.2.3. Calcein-Am Cell Viability Assay Kits
  1.2.4. Other Assay Kits
  1.3. Microplates
  2. Instruments
  2.1. Automated Cell Counters
  2.2. Flow Cytometers
  2.3. Spectrophotometers
  2.4. Cell Imaging and Analysis Systems
8. Global Cell Viability Assays Market, By Cell Type Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Human Cells
  2. Animal Cells
  3. Microbial Cells
9. Global Cell Viability Assays Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Drug Discovery and Development
  2. Basic Research
  3. Stem Cell Research
  4. Clinical and Diagnostic Applications
  5. Other Applications
10. Global Cell Viability Assays Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Pharmaceutical and Biotechnology Companies
  2. Academic and Research Institutes
  3. Hospital and Diagnostic Laboratories
  4. Other End Users
11. North America Cell Viability Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
12. Latin America Cell Viability Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
13. Europe Cell Viability Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
14. Asia Pacific Cell Viability Assays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
15. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2023-2031
16. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. Thermo Fisher Scientific
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Merck KGaA
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Bio-Rad Laboratories
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. GE Healthcare
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. Danaher Corporation
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Becton
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Dickinson and Company
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Promega Corporation
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Biotium
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Abcam PLC
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
  11. Creative Bioarray
  11.1. Company Overview
  11.2. Product Portfolio
  11.3. SWOT Analysis
  11.4. Financial Overview
  11.5. Strategic Overview
  12. Biotek Instruments
  12.1. Company Overview
  12.2. Product Portfolio
  12.3. SWOT Analysis
  12.4. Financial Overview
  12.5. Strategic Overview
  13. PerkinElmer
  13.1. Company Overview
  13.2. Product Portfolio
  13.3. SWOT Analysis
  13.4. Financial Overview
  13.5. Strategic Overview
18. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by
  administrations
  5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients